This milestone follows PharmSight’s recent launch in the U.S. market. With offices in Boston and now Zug, PharmSight is planning expansion into the Middle East and establishing an innovation center ...

A UK biotech firm spent years gathering genetic data that has uncovered 1 million previously unknown microbial species and ...

Sulzer Ltd. (Winterthur, Switzerland) opened its fourth location in Switzerland. The Innovation Technology Hub (InTecH) in Winterthur Töss will further ...

This week's annual BIO International Convention brings a spotlight to a state looking to protect its longstanding life sciences dominance.

Day One officially began on Monday, June 15, 2025, with an automation session chaired by LCGC International’s Pharmaceutical Perspectives columnist, and active member of ChromSoc, Adrian Clarke from ...

The Producer and Import Price Index fell in May 2025 by 0.5% compared with the previous month, reaching 106.4 points ...

Swiss biotechnology companies are stepping up expansion and investments in China, eyeing its huge market potential and improved policies to accommodate foreign capital, said executives and ...

Indonesia is seeking to strengthen its strategic partnership with Switzerland, particularly in the fields of health ...

A split ICC tribunal has rejected claims by Swiss pharmaceutical group Novartis that it has commercial rights over an eye ...

Award-winning Scottish biotechnology company Remora has announced a major milestone in its commercial journey after signing a ...

In Merck’s case, worries over rising competition from so-called ‘biosimilar’ generic products, which approximate the biological chemical structure of branded medicines, is behind much of the ...